Back to results
US 6,730,696 B1Granted
Phospholipid derivatives of non-steroidal anti-inflammatory drugs
AssigneeD-Pharm Ltd.
InventorsAlexander Kozak, Israel Shapiro
Life of this patent
Estimating the term…
Abstract
Disclosed are compounds having non-steroidal anti-inflammatory drugs (NSAIDS) covalently linked to a phospholipid moiety via a bridging group. Also disclosed are a process for the synthesis of the compounds, pharmaceutical compositions comprising the compounds and the use thereof for the treatment of diseases and disorders related to inflammatory conditions, such as the treatment of ischemia.
Claims27
A compound of the general formula I
- or a pharmaceutically acceptable salt thereof, wherein:
- R1 is a saturated unsubstituted hydrocarbon chain having from 2 to 30 carbon atoms;
- R2 is a phospholipid head group selected from the group consisting of choline, ethanolamine, inositol and serine;
- D is indomethacin, wherein D is attached through a functional group to a bridging group, —C(O)—Z—X—, wherein Z is a saturated hydrocarbon chain having from 2 to 15 carbon atoms, and X is selected from amino, and thio groups.
1 more element
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and, as an active ingredient, a compound of the general formula I
- or a pharmaceutically acceptable salt thereof, wherein:
- R1 is a saturated unsubstituted hydrocarbon chain having from 2 to 30 carbon atoms;
- R2 is a phospholipid head group selected from the group consisting of choline, ethanolamine, inositol and serine;
- D is indomethacin, wherein D is attached through a functional group to a bridging group, —C(O)—Z—X—, wherein Z is a saturated hydrocarbon chain having from 3 to 15 carbon atoms, and X is selected from amino and thio.
1 more element
Dependencies are inferred from the claim text.